Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Clinical trial NCT05226897 · UNKNOWN

Trial details

NCT number: NCT05226897
Sponsor: Yooyoung Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-07-12
Primary completion: 2022-10-31
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.